Skip to main content
. 2020 Sep 23;10:15567. doi: 10.1038/s41598-020-72649-5

Figure 3.

Figure 3

Treatment-related adverse events and immune-related adverse events between immune checkpoint inhibitor monotherapy and combination: (A) any grade; (B) grade 1–2; (C) grade 3–5.